Suvretta Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.78M Sell
123,941
-229,620
-65% -$18.4M 0.21% 50
2025
Q4
$33.7M Hold
353,561
0.84% 45
2025
Q3
$34.5M Hold
353,561
1.05% 37
2025
Q2
$38M Buy
353,561
+91,462
+35% +$9.25M 1.43% 32
2025
Q1
$26.4M Sell
262,099
-135,580
-34% -$13.7M 1.07% 32
2024
Q4
$35.5M Buy
397,679
+145,990
+58% +$12.9M 1.32% 30
2024
Q3
$21.1M Hold
251,689
0.76% 46
2024
Q2
$19.4M Sell
251,689
-51,346
-17% -$3.76M 0.79% 40
2024
Q1
$20.8M Sell
303,035
-391,066
-56% -$25.1M 0.88% 40
2023
Q4
$40.1M Buy
694,101
+340,360
+96% +$18.2M 1.83% 19
2023
Q3
$18.7M Buy
353,741
+335,500
+1,839% +$17.6M 1.01% 32
2023
Q2
$987K Hold
18,241
0.05% 87
2023
Q1
$913K Buy
18,241
+4,100
+29% +$193K 0.04% 82
2022
Q4
$654K Buy
+14,141
New +$612K 0.03% 72
2020
Q3
Sell
-455,000
Closed -$16M 98
2020
Q2
$16M Sell
455,000
-4,089,220
-90% -$147M 0.34% 48
2020
Q1
$148M Buy
4,544,220
+2,868,710
+171% +$112M 4% 8
2019
Q4
$75.8M Sell
1,675,510
-43,889
-3% -$1.84M 1.77% 28
2019
Q3
$70M Sell
1,719,399
-949,001
-36% -$40.2M 1.89% 23
2019
Q2
$115M Sell
2,668,400
-409,000
-13% -$15.7M 2.87% 15
2019
Q1
$118M Buy
3,077,400
+778,946
+34% +$29.8M 4.17% 8
2018
Q4
$81.2M Sell
2,298,454
-79,016
-3% -$2.87M 6.09% 8
2018
Q3
$91.5M Buy
+2,377,470
New +$83M 2.13% 16

Other funds holding BSX